Abstract
Ara-A is an effective antiviral agent in the treatment of herpetic ulceration. Its use leads to a quick and high cure rate, and clinical resistance is low. It can successfully be used in cases showing complications after treatment with other antiviral agents.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Clinical Trials as Topic
-
Drug Hypersensitivity
-
Drug Resistance
-
Humans
-
Idoxuridine / adverse effects
-
Idoxuridine / therapeutic use
-
Keratitis, Dendritic / drug therapy*
-
Purine Nucleosides / therapeutic use*
-
Trifluridine / adverse effects
-
Trifluridine / therapeutic use
-
Vidarabine / adverse effects
-
Vidarabine / therapeutic use*
Substances
-
Purine Nucleosides
-
Vidarabine
-
Idoxuridine
-
Trifluridine